Anti-interleukin 4 antibody and indomethacin synergistic effect on B16 melanoma tumor progression

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 472-477

  Blaya, C ^a   Crespo, J ^a   Crespo, A ^a   Alino S F ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INDOMETACIN; INTERLEUKIN 4 ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; DRUG POTENTIATION; EFFECTOR CELL; HOST RESISTANCE; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG METASTASIS; MALE; MELANOMA CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CD4-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; INDOMETHACIN; INTERLEUKIN-4; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PROSTAGLANDIN ANTAGONISTS;

EID: 0030433660     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. ALIÑO S. F., UNDA F. J., PÉREZ-YARZA M. L. AND CAÑAVATE M. L.: Are laminin binding sites on tumor cell surface involved in the indomethacin-induced sensitivity to natural cytotoxic cells? Biol. Cell 66: 255-261, 1989.
2. ALIÑO S. F., UNDA F. J., IRUARRIZAGA A., ALFARO J, HILARIO E, PEREZ-YARZA G, BOBADILLA M. AND LEJARRETA M.: Efficacy of liposome-encapsulated indomethacin in response against metastatic 3LL and BI6F1 tumor cells. Lab. Invest. 66: 671-679, 1992.
3. ALIÑO S. F., LEJARRETA M., ALFARO J., IRUARRIZAGA A., BOBADILLA M., BLAYA, C. AND CRESPO J.: Antimetastatic effect of immunization with liposome-encapsulated tumor cell-membrane proteins obtained from experimental tumors. Immunopharmacol. Immunotoxicol. 17: 419-436, 1995.
4. BOSCO M., GIORVARELLI M., FORNI M., MODESTI A., SCARPA S., MASVELLI L. AND FORNI G.: Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently non-immunogenetic tumors and induce a tumor-specific memory. J. Immunol. 154: 3136-3143, 1990.
5. BRENAN M. AND PARISH C. R.: Automated fluorimetric assay for T cell cytotoxicity. J. Immunol. Methods 112: 121-131, 1988.
6. BRODER S. AND WALDMANN T. A.: The suppressor-cell network in cancer. N. Engl. J. Med. 299: 1281-1284, 1978.
7. FIDLER I. J.: Selection of successive tumor lines for metastasis. Nature 242: 148-149, 1973.
8. GOLUMBEK P., LAZEMBY A., LEVITSKY H. I., JAFEE L. M., KARASUMAYA H., BAKER M. AND PARDOLL D. M.: Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 264: 713-716, 1991.
9. JENKINS M. K., PARDOLL D. M., MIZUZGUCHI J., CHUSED T. M. AND SCHWATZ R. H.: Molecular events in the induction of a non-response state in interleukin-2 producing helper T-lymphocyte clones. Proc. Natl. Acad. Sci. U.S.A. 84: 5409-5413, 1987.
10. LOEFFLER C. M., SMYTH M. J., LONGO D. L. KOPP W. C., HARVEY L. K., TRIBBLE H. R., TASE J. E., URBA W. J., LEONARD A. S., YOUNG H. A. AND OCHOA A. C.: Immunoregulation in cancer-bearing host. Down regulation of gene expression and cytotoxic function in CD8+ T. cells. J. Immunol. 149: 949-956, 1992.
11. MACHY P., ARNOLD B., ALIÑO S. F. AND LESSERMAN L. D.: Interferon sensitive and insensitive MHC variants of a murine thymoma differentially resistant to methotrexate containing antibody-directed liposomes and immunotoxins. J. Immunol. 136: 3110-3115, 1986.
12. MOSMANN T. R. AND COFFMAN R. L.: Th1 and Th2 cells different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173, 1989.
13. SANDERSON A. R. AND BEVERLEY P. C.: Interferon β-2-microglobulin and immunoselection in the pathway to malignancy. Immunol. Today 4: 211-213, 1983.
14. SEDER R. A. AND PAUL W. E.: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12: 635-673, 1994.
15. SEDLMAYR P., RABINOWICH H., ELDER E. M. ERNSTOFF M. S., KIRKWOOD J. M., HERBERMAN R. B. AND WHITESIDE T. L.: Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells. J. Immunother. 10: 336-346, 1991.
16. TEPPER R. I., COFFMAN R. L. AND LEDER P.: An eosinophil-dependent mechanism of the antitumor effect of IL-4. Science 257: 548-551, 1992.
17. VAN DER BRUGGEN P., TRAVERSARI C., CHOMEZ P., LURQUIN C., DE PLAEN E., VAN DER EYNDE B., KNUTH A. AND BOON T.: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647, 1991.
18. VAN PEL A., VESSIERE F. AND BOON T.: Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis. J. Exp. Med. 157: 1992-2001, 1983.
19. WATSON G. A., FU Y. X. AND LOPEZ D. M.: Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms. J. Leukocyte Biol. 49: 126-138, 1991.